Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Head and Neck Cancer Diagnostics Market

  • MAR2979334
  • 186 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Introduction

Head and Neck cancers can be called as the various types of malignant tumors grown in and around head and neck and are one of the most deadly type of cancers in the world. They initiate in squamous cells that line the mucosal surface of head and neck and are called as squamous cell carcinoma. The symptoms for these cancers include headache, common cold, change in voice, soreness in the mouth, and swelling of jaws.

They are among the ten most common types of cancers worldwide and are especially prevalent in regions where consumption of alcohol and tobacco is high. Overall, head and neck cancers account for more than 550,000 cases annually all over the world. The early detection and prompt treatment offer the best chance for cure of these diseases.

Market Dynamics

The market for head and neck cancer diagnostics is expected to grow immensely. Some of the major trends driving the market are the rising cases of target diseases, growing aging population that increased the prevalence of chronic diseases, increasing number of diagnostic procedures for head and neck cancer, and better healthcare initiatives by governments and various private organizations. Increasing disposable incomes that lead to rise in the healthcare expenditure of people, rising demand for diagnostic imaging, advances in treatment modes, and incorporation of novel technologies in diagnostic equipment will further propel market growth during the forecast period.

Restraints

Some of the restraining factors for this market includes the low adoption rate of digital technology-based systems, conventional CT and MRI scanners, excise duty imposed on sale of medical devices in mature markets, unfavorable government regulations regarding new researches, high cost associated with the treatment modes and lack of awareness among the people.

Market Segmentation

The global head & neck cancer market can be segmented on the basis of type of cancer, diagnostic technique, type of treatment, and end-user.

On the Basis of Cancer Type:

> Salivary gland cancer

> Oropharyngeal (oral cavity) cancer

> Nasopharyngeal cancer

> Laryngeal cancer

On the Basis of Diagnostic Technique:

> Diagnostic imaging

>> PET/CT

>> MRI

>> X-ray

>> Barium Swallow test

> Biopsy

>> PET/CT

>> MRI

>> X-ray

>> Barium Swallow test

> Endoscopy

>> PET/CT

>> MRI

>> X-ray

>> Barium Swallow test

> Dental diagnostics

>> Fluorescence Visualization

>> Toluidine blue dye based method

>> Acetic acid rinse method

>> Brush biopsy

On the Basis of Treatment Type:

> Surgery

> Chemotherapy

> Radiation therapy

> Targeted therapy

On the Basis of End-User:

> Hospitals

> Ambulatory surgical centres

> Clinics

Regional/Geographic Analysis

Based on geography the market is divided into five regions viz. North America, Europe, Asia- Pacific, Latin America and Middle-East & Africa. North America accounts for maximum share of the global market and is estimated to remain dominant in terms of revenue, which can be attributed to the rising investment by key players in R&D activities and technological advancements in the medical sector in this region. The market in Asia Pacific is also expected to expand owing to the improving health care facilities and rising awareness among the people. Countries like Africa and Asia-Pacific, along with parts of Europe and South America, have the highest incidence of head and neck cancer cases due to huge consumption of alcoholic and tobacco products in these regions. In Asia-Pacific and Africa, India, China, and South Africa are the biggest markets for the overall head and neck cancer diagnostics market.

Key Players

The key market players in the market are -

> Philips Healthcare

> Identafi

> Varian Medical Systems

> Siemens Healthcare

> AdDent Inc.

> GE Healthcare

> Velscope VX

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390